12-Year-Old Boy With Chronic Budd-Chiari Syndrome, Presenting With Recurrent Abdominal Pain and Distention, After Undergoing Left Hepatic Vein Angioplasty.

12-Year-Old Boy With Chronic Budd-Chiari Syndrome, Presenting With Recurrent Abdominal Pain and Distention, After Undergoing Left Hepatic Vein Angioplasty. Liver stiffness measurement before (A) and 24 hours after (B) intervention shows a decrease from 44.1 kPa to 26.4 kPa.


October 6, 2021 — According to ARRS’ American Journal of Roentgenology (AJR), liver stiffness measurements (LSM) obtained by 2D shear-wave elastography (SWE) may serve as a useful quantitative adjunct to Color Doppler ultrasound (CDUS) in monitoring children with chronic Budd-Chiari syndrome (BCS) for disease recurrence after percutaneous interventional treatment.

“LSM decreased significantly after image-guided intervention for chronic BCS in children, showing a maximal decrease at 24 hours post-intervention,” wrote corresponding author Sanjay Sharma from the department of radiodiagnosis and interventional radiology at the All India Institute of Medical Sciences in New Delhi. “Disease recurrence was typically associated with an increase in LSM, compared with the patient’s prior measurement.”

Sharma and team’s prospective study included children with chronic BCS and planned image-guided intervention. CDUS and 2D SWE were performed at baseline; at 24 hours, one month, and three months after intervention; and thereafter every three months or at the time of clinically suspected recurrence.

In the 32 children (28 boys, 4 girls; mean age, 9.0 years) who underwent image-guided intervention for chronic BCS, median LSM was 43.7 kPa at baseline and 22.5 kPa, 18.7 kPa, and 16.7 kPa at 24 hours, one month, and three months, respectively, after intervention. In eight of nine patients with recurrence, LSM was increased, compared with the pre-recurrence measurement.

“The stage of histologic liver fibrosis was not significantly correlated with LSM at any time point, possibly due to the confounding effect of liver congestion,” added the authors of this AJR article.

For more information: www.arrs.org


Related Content

News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 23, 2024 — Researchers at the National Institutes of Health (NIH) found that an artificial intelligence (AI) model ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 22, 2024 — Healthcare artificial intelligence (AI) systems provider, Qure.ai, has announced its receipt of a Class ...

Time July 22, 2024
arrow
News | Radiology Business

July 19, 2024 — GE HealthCare announced it has entered into an agreement to acquire Intelligent Ultrasound Group PLC’s ...

Time July 19, 2024
arrow
News | Radiology Education

July 19, 2024 — Core tactics to address the current medical imaging and radiation therapy workforce shortage and build ...

Time July 19, 2024
arrow
News | Computed Tomography (CT)

July 18, 2024 — NeuroLogica Corp, a subsidiary of Samsung Electronics Co. Ltd., announced its latest configuration of ...

Time July 18, 2024
arrow
News | Digital Radiography (DR)

July 18, 2024 — At the Annual Meeting of AHRA (the Association for Medical Imaging Management), Agfa Radiology Solutions ...

Time July 18, 2024
arrow
News | Artificial Intelligence

July 17, 2024 — Hyperfine, a groundbreaking medical device company that has redefined brain imaging with the world’s ...

Time July 17, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

July 16, 2024 — Fujifilm Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging ...

Time July 16, 2024
arrow
Subscribe Now